Zobrazeno 1 - 10
of 121
pro vyhledávání: '"Oteri, J."'
Autor:
Nwachukwu, William E., Yusuff, H., Nwangwu, U., Okon, A., Ogunniyi, A., Imuetinyan-Clement, J., Besong, M., Ayo-Ajayi, P., Nikau, J., Baba, A., Dogunro, F., Akintunde, B., Oguntoye, M., Kamaldeen, K., Fakayode, O., Oyebanji, O., Emelife, O., Oteri, J., Aruna, O., Ilori, E., Ojo, O., Mba, N., Nguku, P., Ihekweazu, C.
Publikováno v:
In International Journal of Infectious Diseases March 2020 92:189-196
Autor:
Wonodi C; International Vaccine Access Center, Bloomberg School of Public Health, Johns Hopkins University, United States. Electronic address: cwonodi1@jhu.edu., Crowcroft N; Department of Immunization Vaccines & Biologicals, World Health Organization, Geneva, Switzerland., Bose AS; Department of Immunization Vaccines & Biologicals, World Health Organization, Geneva, Switzerland., Oteri J; National Primary Health Care Development Agency, Abuja, Nigeria., Momoh J; World Health Organization, FCT office, Abuja, Nigeria., Hughes G; The British Embassy in Mexico City, Mexico., Shet A; International Vaccine Access Center, Bloomberg School of Public Health, Johns Hopkins University, United States., Pradhan R; World Health Organization, Immunization Preventable Disease Program, Nepal., Gautam JS; Family Welfare Division, Dept. of Health Services, Nepal., Jean Baptiste AE; World Health Organization, Country Office, Nigeria., Khanal S; World Health Organization, Regional Office for South-East Asia, India., Masresha B; World Health Organization, Regional Office for Africa, Congo-Brazzaville., Linstrand A; Department of Immunization Vaccines & Biologicals, World Health Organization, Geneva, Switzerland.
Publikováno v:
Vaccine [Vaccine] 2024 Apr 08; Vol. 42 Suppl 1, pp. S107-S117. Date of Electronic Publication: 2023 Oct 13.
Autor:
Jean Baptiste AE; World Health Organization, Country Office, Abuja, Nigeria. jeanbaann@paho.org., Van der Schans J; Department of Economics, Econometrics and Finance, Faculty of Economics & Business, University of Groningen, Groningen, The Netherlands., Bawa S; World Health Organization, Country Office, Abuja, Nigeria., Masresha B; World Health Organization, African Regional Office, Brazzaville, Congo., Wagai J; World Health Organization, Country Office, Abuja, Nigeria., Oteri J; National Primary Health Care Development Agency, Abuja, Nigeria., Dieng B; Technical Assistance Consultant, Global Alliance for Vaccines and Immunizations (GAVI), Abuja, Nigeria., Soyemi M; United Nations Children's Fund (UNICEF) - Country Office for Nigeria, Abuja, Nigeria., Eshuchi R; United Nations Children's Fund (UNICEF) - Country Office for Nigeria, Abuja, Nigeria., Yehualashet YG; World Health Organization, Country Office, Abuja, Nigeria., Afolabi O; World Health Organization, Country Office, Abuja, Nigeria., Braka F; World Health Organization, Country Office, Abuja, Nigeria., Bita A; World Health Organization, African Regional Office, Brazzaville, Congo., Hak E; Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands.
Publikováno v:
Health economics review [Health Econ Rev] 2023 Jun 13; Vol. 13 (1), pp. 36. Date of Electronic Publication: 2023 Jun 13.
Autor:
Korave J; Primary Health Care Development Board, Benue State, Nigeria., Bawa S; World Health Organization, Country Office, Abuja, Nigeria. Electronic address: bawasa@who.int., Ageda B; Primary Health Care Development Board, Benue State, Nigeria., Ucho A; Benue State University, Makurdi, Nigeria., Bem-Bura DM; Benue State University, Makurdi, Nigeria., Onimisi A; World Health Organization, Country Office, Abuja, Nigeria., Dieng B; Technical Assistance Consultant, Global Alliance for Vaccines and Immunizations, United States., Nsubuga P; Global Public Health Solutions, Atlanta, United States., Oteri J; National Primary Health Care Development Agency, Abuja, Nigeria., Fiona B; World Health Organization, Country Office, Abuja, Nigeria., Shuaib F; National Primary Health Care Development Agency, Abuja, Nigeria.
Publikováno v:
Vaccine [Vaccine] 2021 Nov 17; Vol. 39 Suppl 3, pp. C76-C81. Date of Electronic Publication: 2021 Jan 16.
Autor:
Oteri J; National Primary Health Care Development Agency, Abuja, Nigeria. Electronic address: joseph.oteri@nphcda.gov.ng., Idi Hussaini M; Volunteer, National Measles Technical Coordinating Committee, Nigeria., Bawa S; World Health Organization, Country Office, Abuja, Nigeria., Ibizugbe S; Clinton Health Access Initiative (CHAI), Abuja, Nigeria., Lambo K; Clinton Health Access Initiative (CHAI), Abuja, Nigeria., Mogekwu F; National Primary Health Care Development Agency, Abuja, Nigeria., Wiwa O; Clinton Health Access Initiative (CHAI), Abuja, Nigeria., Seaman V; Bill and Melinda Gate Foundation, Seattle, USA., Kolbe-Booysen O; e - Health Africa, Nigeria., Braka F; World Health Organization, Country Office, Abuja, Nigeria., Nsubuga P; Global Public Health Solutions, Atlanta, USA., Shuaib F; National Primary Health Care Development Agency, Abuja, Nigeria.
Publikováno v:
Vaccine [Vaccine] 2021 Nov 17; Vol. 39 Suppl 3, pp. C29-C37. Date of Electronic Publication: 2021 Jan 19.
Autor:
Hamisu M; National Primary Health Care Development Agency, Abuja, Nigeria., Dieng B; Technical Assistance Consultant, Global Alliance for Vaccines and Immunizations., Taiwo L; Nigeria Field Epidemiology & Laboratory Training Program (NFELTP), Abuja, Nigeria., Jean Baptiste AE; World Health Organization, Country Office, Abuja, Nigeria. Electronic address: jeana@who.int., Bawa S; World Health Organization, Country Office, Abuja, Nigeria., Wagai J; World Health Organization, Country Office, Abuja, Nigeria., Ibizugbe S; Clinton Health Access Initiative (CHAI), Abuja, Nigeria., Braka F; World Health Organization, Country Office, Abuja, Nigeria., Nsubuga P; Global Public Health Solutions, Atlanta GA, USA., Shuaib F; National Primary Health Care Development Agency, Abuja, Nigeria., Oteri J; National Primary Health Care Development Agency, Abuja, Nigeria.
Publikováno v:
Vaccine [Vaccine] 2021 Nov 17; Vol. 39 Suppl 3, pp. C46-C53. Date of Electronic Publication: 2021 Apr 21.
Autor:
Terna Richard M; Clinton Health Access Initiative (CHAI), Abuja, Nigeria., Taiwo L; Nigeria Field Epidemiology & Laboratory Training Program (NFELTP), Abuja, Nigeria., Jean Baptiste AE; World Health Organization, Country Office, Abuja, Nigeria. Electronic address: jeana@who.int., Bawa S; World Health Organization, Country Office, Abuja, Nigeria., Dieng B; Technical Assistance Consultant, Global Alliance for Vaccines and Immunizations, Nigeria., Wiwa O; Clinton Health Access Initiative (CHAI), Abuja, Nigeria., Lambo K; Clinton Health Access Initiative (CHAI), Abuja, Nigeria., Braka F; World Health Organization, Country Office, Abuja, Nigeria., Shuaib F; National Primary Health Care Development Agency, Abuja, Nigeria., Oteri J; National Primary Health Care Development Agency, Abuja, Nigeria.
Publikováno v:
Vaccine [Vaccine] 2021 Nov 17; Vol. 39 Suppl 3, pp. C21-C28. Date of Electronic Publication: 2021 Jul 08.
Autor:
Gbenewei E; National Primary Health Care Development Agency, Nigeria., Nomhwange T; World Health Organization Country Office Nigeria, Nigeria. Electronic address: nomhwanget@who.int., Taiwo L; AFENET Country Office Nigeria, Nigeria., Ayodeji I; World Health Organization Country Office Nigeria, Nigeria., Yusuf K; National Primary Health Care Development Agency, Nigeria., Jean Baptiste AE; World Health Organization Country Office Nigeria, Nigeria., Nsubuga P; Global Health Solutions, Atlanta, GA, USA., Braka F; World Health Organization Country Office Nigeria, Nigeria., Oteri J; National Primary Health Care Development Agency, Nigeria., Shuaib F; National Primary Health Care Development Agency, Nigeria.
Publikováno v:
Vaccine [Vaccine] 2021 Nov 17; Vol. 39 Suppl 3, pp. C82-C88. Date of Electronic Publication: 2021 Mar 11.
Autor:
Jean Baptiste AE; World Health Organization, Country Office, Abuja, Nigeria. Electronic address: jeana@who.int., Masresha B; World Health Organization, African Regional Office, Brazzaville, Congo., Wagai J; World Health Organization, Country Office, Abuja, Nigeria., Luce R; World Health Organization, Inter-country Support Team for West Africa, Ouagadougou, Burkina Faso., Oteri J; National Primary Health Care Development Agency, Abuja, Nigeria., Dieng B; Technical Assistance Consultant, Global Alliance for Vaccines and Immunizations, Nigeria., Bawa S; World Health Organization, Country Office, Abuja, Nigeria., Ikeonu OC; World Health Organization, Country Office, Abuja, Nigeria., Chukwuji M; World Health Organization, Country Office, Abuja, Nigeria., Braka F; World Health Organization, Country Office, Abuja, Nigeria., Sanders EAM; Department of Pediatric Immunology and Infectious Diseases, University Medical Center Utrecht, the Netherlands., Hahné S; Department of Pediatric Immunology and Infectious Diseases, University Medical Center Utrecht, the Netherlands., Hak E; Groningen Research Institute of Pharmacy, University of Groningen, Groningen, the Netherlands.
Publikováno v:
Vaccine [Vaccine] 2021 Nov 17; Vol. 39 Suppl 3, pp. C89-C95. Date of Electronic Publication: 2021 Apr 17.
Autor:
Okoronkwo C; National Primary Health Care Development Agency (NPHCDA), Nigeria., Taiwo LA; African Field Epidemiology Network (AFENET), Nigeria. Electronic address: ltaiwo@afenet.net., Asolo JA; Clinton Health Access Initiative, Nigeria., Jean Baptiste AE; World Health Organization (WHO), Nigeria., Wagai J; World Health Organization (WHO), Nigeria., Nsubuga P; Global Public Health Solutions, Atlanta, GA, USA., Braka F; World Health Organization (WHO), Nigeria., Shuaib F; National Primary Health Care Development Agency (NPHCDA), Nigeria., Oteri J; National Primary Health Care Development Agency (NPHCDA), Nigeria.
Publikováno v:
Vaccine [Vaccine] 2021 Nov 17; Vol. 39 Suppl 3, pp. C54-C59. Date of Electronic Publication: 2021 May 20.